Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,63 USD | -2,85% | -7,27% | -20,47% |
Omzet 2024 * | 33,61 mln. 31,43 mln. | Omzet 2025 * | 64,29 mln. 60,12 mln. | Marktkapitalisatie | 57,61 mln. 53,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -47 mln. -43,96 mln. | Nettowinst (verlies) 2025 * | 5 mln. 4,68 mln. | EV/omzet 2024 * | 1,71 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,9 x |
K/w-verhouding 2024 * |
-1,3
x | K/w-verhouding 2025 * |
2,48
x | Werknemers | 69 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,66% |
Recentste transcriptie over Cidara Therapeutics, Inc.
1 dag | -2,85% | ||
1 week | -7,27% | ||
Lopende maand | -31,36% | ||
1 maand | -14,66% | ||
3 maanden | -5,02% | ||
6 maanden | -21,89% | ||
Lopend jaar | -20,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 01-01-14 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 01-09-21 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 01-04-14 |
Director/Board Member | 69 | 01-04-14 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 01-01-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 12,63 | -2,85% | 200 108 |
25-04-24 | 13 | +5,78% | 753 807 |
24-04-24 | 12,29 | +19,90% | 326 436 |
23-04-24 | 10,25 | -0,27% | 96 083 |
22-04-24 | 10,28 | -24,54% | 192 657 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,47% | 57,61 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |